SKI Market

Indian Indices

Nifty

26,192.15 139.50
(0.54%)

Sensex

85,225.22 -407.46
( -0.48%)

Bank Nifty

59,347.70 131.65
( 0.22%)

Nifty IT

37,043.30 -1.35
( 0.00%)

Global Indices

Nasdaq

45,781.42 -378.36
(-0.82%)

Dow Jones

6,560.44 -102.72
(-1.54%)

Hang Seng

49,837.83 1,300.13
(2.68%)

Nikkei 225

9,572.31 64.90
(0.68%)

Forex

USD-INR

88.50 -0.07
(-0.08%)

EUR-INR

102.33 -0.31
(-0.31%)

GBP-INR

115.99 -0.49
(-0.42%)

JPY-INR

0.57 0.00
(-0.62%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indo US Bio-Tech Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

541304

INE250Z01010

43.2221225

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INDOUS

14.41

243.63

EPS(TTM)

Face Value()

Div & Yield %

8.43

Back

akzo nobel india ltd

Scan Projects standalone net profit rises 433.33% in the September 2025 quarter

Nov 19,2025

Net profit of Scan Projects rose 433.33% to Rs 0.16 crore in the quarter ended September 2025 as against Rs 0.03 crore during the previous quarter ended September 2024. Sales rose 24.93% to Rs 4.26 crore in the quarter ended September 2025 as against Rs 3.41 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	4.26	3.41	25
OPM %	4.23	0.88	-
PBDT	0.26	0.05	420
PBT	0.25	0.04	525
NP	0.16	0.03	433

26,192.15 139.50 (0.54%)

85,225.22 -407.46 ( -0.48%)

59,347.70 131.65 ( 0.22%)

37,043.30 -1.35 ( 0.00%)

45,781.42 -378.36 (-0.82%)

6,560.44 -102.72 (-1.54%)

49,837.83 1,300.13 (2.68%)

9,572.31 64.90 (0.68%)

88.50 -0.07 (-0.08%)

102.33 -0.31 (-0.31%)

115.99 -0.49 (-0.42%)

0.57 0.00 (-0.62%)